ALARIS PUMP MODULE
Report
- Report Number
- 2016493-2015-00441
- Event Type
- Injury
- Date Received
- June 10, 2015
- Date of Event
- May 28, 2014
- Report Date
- May 18, 2015
- Manufacturer
- CAREFUSION
- Product Code
- FRN
- PMA / PMN Number
- K950419
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- OTHER
Narratives
ALTHOUGH REQUESTED, THE AFFECTED PRODUCT HAS NOT BEEN RECEIVED. A FOLLOW UP REPORT WILL BE SUBMITTED WITH INVESTIGATION RESULTS SHOULD THE DEVICES BE RECEIVED FOR EVALUATION.
THE CUSTOMER 'S (B)(4) REPORT STATES "PATIENT WAS ADMITTED WITH NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION (NSTEMI) . THREE DAYS LATER, THE PATIENT WAS ON AMIODARONE, HEPARIN AND NOREPINEPHRINE DRIPS. DURING THE NIGHT SHIFT. THE NURSE ON DUTY HAD TO TITRATE NOREPINEPHRINE (CONCENTRATION 8MG/250 ML) FROM 0.06MCG/KG/MIN , TO 0.07 ONE HOUR LATER, TO 0.08 SEVEN HOURS LATER. BP HAD BEEN MAINTAINED APPROXIMATELY 88/68 BY ARTERIAL LINE, 90/63 BY CUFF UNTIL THE END OF TITRATION. SEVERAL HOURS LATER, THE PT WAS ON 0.4MCG/KG/MIN AND BP 205/123 BY ART LINE, 182/133 BY CUFF. AN HOUR LATER THE CONCENTRATION OF NOREPINEPHRINE WAS CHANGED TO 32 MG/500 ML AND DOSE WAS AT 0.4 MCG/KG/MIN. BP CONTINUED TO BE 161/102 BY ART LINE, CUFF PRESSURE 111/26. WITHIN 10 MINUTES, THE NOREPINEPHRINE WAS WEANED TO 0.2 MCG/KG/MIN. THE DOCTOR EXPRESSED CONCERN AS PATIENT WAS REPORTED AS BEING ON .08MCG BUT FOUND THE UMP AT 0.8 MCG. WHILE THEY WERE TROUBLESHOOTING THE RESPIRATORY THERAPIST CAME IN TO ASSESS ARTERIAL LINE AND AFTER LEVELLING AND ZEROING BP WAS FOUND TO BE SO ELEVATED. THE PUMP WAS REPROGRAMMED TO INITIAL MEDICATION CALCULATED WEIGHT FROM ICU. THE PUMP WAS TAKEN OUT OF PATIENT ROOM AT WHICH TIME THIS EVENT IS REPORTED. PUMP "BRAIN" CE 76034, NOREPINEPHRINE CHANNEL CE70420."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 378822 | ALARIS PUMP MODULE | PUMP, INFUSION | FRN | CAREFUSION | 8100 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 62 YR | Other |